Please assess the completion status of the following clinical trial:

Trial Title: A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients who fulfil ALL the following criteria are included.~1. Patients who diagnosed with COPD who were prescribed with LABA/LABA (FDC or free combo) as a new initiation or switching from other therapy (i.e., single/dual/triple), or newly receiving LAMA treatment for 3 months at least prior to 30 June 2018~2. Male or female patients ≥ 40 years of age~Exclusion Criteria:~1. Patients who meet the following criterion are not included.~* Patients with documented diagnosis of bronchial asthma, asthma-COPD overlap syndrome (ACOS), bronchiectasis, cystic fibrosis, or lung cancer

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Subjects with Tiotropium and Olodaterol (Type: None): None
- Subjects treated with other LABA/LAMA therapy (Type: None): None
- Subjects treated with LAMA therapy (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).